BRK.B enters its most watched weekend in years with options traders positioned more optimistically than at any point in the past twelve months — and short sellers quietly retreating.
The clearest signal comes from the options market. The put/call ratio has dropped to 0.51, the lowest reading of the past 52 weeks and more than two standard deviations below its 20-day average of 0.56. That's an unusually clean call-heavy skew for a conglomerate of this size. The move reflects genuine appetite for upside exposure ahead of Saturday's Q1 earnings release and Greg Abel's first annual general meeting as chief executive. Abel himself appears to have added to the conviction: ORTEX flagged a high-importance headline Tuesday evening reporting that the incoming CEO bought shares ahead of Saturday's results — a signal the market will not easily ignore.
Short interest adds almost nothing to the tension. Bears hold roughly 0.79% of the free float — a position that has actually shed about 7.7% over the past week as shorts covered into the rally. The borrow market is equally relaxed. Cost to borrow runs at 1.37% annualised, barely changed over the month, and availability in the lending pool remains wide. There is no squeeze dynamic, no meaningful short overhang, and no evidence of a crowd building a thesis against the stock. The ORTEX short score of 29 — ranking in the 92nd percentile for low short pressure — confirms the picture: this is not a name where positioning conflict is the story.
The valuation picture is straightforward. The stock trades at a trailing P/E of 22.8x and 1.32x book — a modest premium to its long-run norm but not an aggressive one given the scale of Berkshire's cash holdings. EPS surprise scores in the 90th percentile, meaning the company has a long record of printing above consensus. EPS momentum over the past 30 days ranks in the 70th percentile, though the 90-day figure has weakened sharply to the 9th percentile — a divergence worth watching as Abel sets his first forward-guidance tone. Analyst data in the snapshot is heavily stale (last confirmed ratings from 2022) and should not be treated as current guidance on fair value. The EV figure, negative given Berkshire's enormous cash pile relative to debt, simply reflects the conglomerate's distinctive balance sheet architecture rather than any valuation anomaly.
The ownership register is a familiar cast. Warren Buffett retains a 13.6% stake via 196,315 B-share equivalents, essentially unchanged. Vanguard added around 1,900 shares to reach 7.6%, while BlackRock added 4,265 shares to reach 5.6% — both movements consistent with passive index rebalancing rather than active conviction shifts. The Bill & Melinda Gates Foundation Trust trimmed 1,573 shares as of December, continuing a gradual reduction that has been running for several years. No insider trades appear in the 90-day window: the most recent filed transaction is Ajit Jain's September 2025 sale of 15,000 shares at around $501 — above the current $478.16 price — though that data is now stale relative to the current setup.
The last two earnings releases produced negative one-day reactions: a 4.9% drop after the February 2026 print and a 0.6% move after March's event. The five-day windows were also negative, suggesting the market has been inclined to sell into results rather than chase them. Saturday's release is therefore less a conventional beat-or-miss event and more a referendum on Abel's capital allocation priorities — how he addresses the record cash stockpile, whether acquisition appetite has changed, and how explicitly he distances himself from Buffett's more macro-cautious public posture of recent quarters.
See the live data behind this article on ORTEX.
Open BRK.B on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
